Instituto Rosenbusch (BUE:ROSE) FFO


BUE:ROSE Instituto Rosenbusch SA BUE:ROSE
39 GF Score
Price ARS162.00
GF Value ARS61.70
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Instituto Rosenbusch FFO?

FFO (Funds from operations) only applies to REITs.

BUE:ROSE
39GF Score
Instituto Rosenbusch SA BUE:ROSE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?

Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued. The current stock price of ARS162.00 is trading 162.6% above its estimated GF Value™ of ARS61.70. GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.

Key valuation signals for BUE:ROSE:

  • FFO:
  • GF Value™: ARS61.70 vs. price of ARS162.00 (162.6% above fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Instituto Rosenbusch Business Description

Address Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
39GF Score

Get the complete analysis for BUE:ROSE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS162.00
Price
ARS61.70
GF Value